Gonadotrophin releasing hormone agonist treatment with or without recombinant human GH in adopted children with early puberty

Clinical Endocrinology

Volumn 55, Issue 1, 2001, Pages 121-129

  Mul, D ^a   Oostdijk, W ^a,b   Waelkens, J J J ^c   Schulpen, T W J ^d   Drop, S L S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; HUMAN GROWTH HORMONE; SOMATOMEDIN C; TRIPTORELIN;

ADOPTION; ARTICLE; BONE AGE; BONE MATURATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEIGHT; HORMONAL THERAPY; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOPTION; ANTHROPOMETRY; BODY HEIGHT; CHILD; DRUG THERAPY, COMBINATION; EMIGRATION AND IMMIGRATION; FEMALE; FOLLOW-UP STUDIES; GROWTH; HUMAN GROWTH HORMONE; HUMANS; LUTEOLYTIC AGENTS; MALE; PROSPECTIVE STUDIES; PUBERTY, PRECOCIOUS; TRIPTORELIN;

EID: 0035724632     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2001.01315.x     Document Type: Article

References (45)

1. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty
2. Effects of changes in nutritional conditions on timing of puberty: Clinical evidence from adopted children and experimental studies in the male rat
3. The long-term effects of protein energy malnutrition in early childhood on bone age, bone cortical thickness and height
4. Bone age assessment: A large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods
5. Children of foreign origin adopted in France. Analysis of 68 cases during l2 years at the University Hospital Center of Tours
6. Gonadotropin releasing hormone agonist treatment for central precocious puberty
7. Childhood growth and age at menarche
8. Fetal growth, length of gestation, and polycystic ovaries in adult life
9. Pelvic ultrasound measurements in normal girls
10. Leptin, nutrition, and reproduction: Timing is everything
11. Issues in final height prediction
12. Indian average population. Growth and physical development of Indian infants and children
13. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precoccious puberty
14. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty
15. Final height of girls with central precocious puberty, untreated versus treated with cyproteron acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method
16. Combined use of growth hormone and gonadotropin-releasing hormone analogues: The national cooperative growth study experience
17. Effect of malnutrition on bones of hand in children
18. Pubertas praecox vera bei einem indischen ma dchen nach adoption durch deutsche eltern
19. Auxological and biochemical evaluation of pubertal suppression with the GnRH agonist leuprolide acetate in early and precocious puberty
20. Psychological assessments before and after treatment of early puberty in adopted children
21. Long-term results with a slow release gonadotrophin-releasing hormone agonist in central precocious puberty
22. Final height and timing of puberty of adopted children in The Netherlands
23. Final height in central precocious puberty after long-term treatment with a slow-release GnRH agonist
24. The impact of early puberty on final height in foreign born, adopted children in The Netherlands. Central precocious puberty and gonadotropin releasing hormone agonist treatment
25. Leptin levels in children with central precocious puberty
26. Bedeutung und charakteristika des LHRH-testes in der diagnostik der vorzeitigen pubertatsentwick-lung bei madchen: Der stimulierte LH/FSH-quotient differenziert zwischen zentraler pubertas praecox und pramaturer thelarche
27. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: Influence on growth and predicted final height
28. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty
29. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone
30. Single occasion means of height and weight of SriLankan Tamil children from Jaffna
31. Skeletal maturity of well-off children in Chandigarh, North India
32. Menarcheal age and growth pattern of Indian girls adopted in Sweden I menarcheal age
33. Menarcheal age and growth pattern of Indian girls adopted in Sweden. II. Catch-up growth and final height
34. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency
35. Growth diagrams 1980. Netherlands third nation-wide survey
36. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis
37. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: Results of a randomized dose-response trial
38. Clinical longitudinal standards for height,weight,height velocity, and stages of puberty
39. Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment
40. The role of estrogen in the control of rat osteocyte apoptosis
41. Growth hormone treatment during suppression of early puberty in adopted girls
42. Precocious puberty in girls adopted from developing countries
43. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: Theoretic and practical considerations
44. The validity of body mass index for the assessment of adiposity in children with disease states